Fairfield, Bush & Co. Qiagen N.V. Transaction History
Fairfield, Bush & Co.
- $169 Billion
- Q1 2024
Shares
2 transactions
Others Institutions Holding QGEN
# of Institutions
31Shares Held
6.76MCall Options Held
0Put Options Held
0-
Pendal Group LTD4.3MShares$177 Million1.76% of portfolio
-
Abeille Asset Management Sa931KShares$38.3 Million1.68% of portfolio
-
Grandeur Peak Global Advisors, LLC Salt Lake City, UT768KShares$31.6 Million2.68% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL345KShares$14.2 Million0.0% of portfolio
-
Pictet Asset Management Sa Geneva 73, V8153KShares$6.31 Million0.01% of portfolio
About QIAGEN N.V.
- Ticker QGEN
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 227,694,000
- Market Cap $9.36B
- Description
- QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...